Enzymotec, a leading supplier of lipid based solutions, is expanding into the Mexican market with its K•REAL® krill oil due to a commercial cooperation with Farmacias Similares®, who is launching SIMIKRILL®, which will be widely available throughout over 5,000 of their outlets in the country.
Víctor González Herrera, Commercial Director of Farmacias Similares, the largest pharmacy chain in South America said: "We have seen a growing need for krill oil, since it provides beneficial omega 3 solution with an improved consumer experience—smaller capsules, reduced fishy burps and better absorption of omega-3 fatty acids into target organs. We believe supplying our customers with SIMIKRILL krill oil, will achieve one of our goals, which is to bring innovative and quality products available to everyone."
“Mexico is a growth market for Enzymotec and this new commercial relationship with Farmacias Similares will enable us to deliver consumers the health benefits of a premium omega 3 product" said Elzaphan Hotam, president and chief executive officer of Enzymotec USA Ltd. "As a leading expert in lipid technology, Enzymotec has developed unique processes that are implemented in the production of its krill oil. This specialized and proprietary technology called the Multi Stage Oil Extraction (MSO®), guarantees krill oil’s freshness and preserves the natural composition of omega-3 fatty acids throughout its shelf life. In addition, it improves the organoleptic properties of the krill oil.”